Here, we demonstrate the following: correlation between PLG and LVEDD; LAD (in a clinical study); degradation of fibronectin and collagen by legumain in vitro; therapeutic effects of legumain inhibitor, RR-11a, for improving cardiac function and attenuating cardiac remodelling post-MI in mice. The gene discussed is LGMN; the disease is myocardial infarction.